PULMOBIOMED LTD

Active Newcastle Upon Tyne

Research and experimental development on biotechnology

8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
P

PULMOBIOMED LTD

Research and experimental development on biotechnology

Founded 9 Apr 2020 Active Newcastle Upon Tyne, United Kingdom 8 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 27 Nov 2025 Next due 31 Jan 2027 9 months remaining
Confirmation Submitted 12 Jun 2025 Next due 26 Jun 2026 2 months remaining
Net assets £405K £745K 2025 year on year
Total assets £1M £86K 2025 year on year
Total Liabilities £753K £659K 2025 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Rmt Accountants & Business Advisors Ltd Gosforth Park Avenue Newcastle Upon Tyne NE12 8EG United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PULMOBIOMED LTD (12552857), an active life sciences and medical technology company based in Newcastle Upon Tyne, United Kingdom. Incorporated 9 Apr 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2021–2025)

Cash in Bank

£740.95k

Decreased by £337.46k (-31%)

Net Assets

£405.22k

Decreased by £745.29k (-65%)

Total Liabilities

£753.16k

Increased by £659.38k (+703%)

Turnover

N/A

Employees

8

Increased by 4 (+100%)

Debt Ratio

65%

Increased by 57 (+713%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1
Grants 1

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 2Feb 2024Seed
Investor 3Feb 2024Seed
Investor 4Feb 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 5,344,810 Shares £2.13m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
18 Jan 2024172,872£45k£0.26
14 Dec 20235,077,424£1.32m£0.26
14 Dec 202384,515£22k£0.26
2 Dec 20201,500£23k£15
2 Dec 20208,499£722k£84.99

Officers

Officers

1 active 2 resigned
Status
Sterghios MoschosDirectorGreekUnited Kingdom479 Apr 2020Active

Shareholders

Shareholders (14)

Sterghios Moschos
31.7%
University Of Northumbria
26.0%

Persons with Significant Control

Persons with Significant Control (2)

2 Active

University Of Northumbria At Newcastle

United Kingdom

Active
Notified 2 Dec 2020
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Sterghios Moschos

Greek

Active
Notified 9 Apr 2020
Residence United Kingdom
DOB January 1979
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Nov 2025AccountsAnnual accounts made up to 2025-04-30
12 Jun 2025Confirmation StatementConfirmation statement made on 2025-06-12 with no updates
6 Jun 2025Persons With Significant ControlChange to Dr Sterghios Moschos as a person with significant control on 2023-12-13
2 Jun 2025OfficersTermination of Huw Alun Edwards as director on 2025-06-01
1 Jun 2025OfficersTermination of Peter Martin Hotten as director on 2025-06-01
27 Nov 2025 Accounts

Annual accounts made up to 2025-04-30

12 Jun 2025 Confirmation Statement

Confirmation statement made on 2025-06-12 with no updates

6 Jun 2025 Persons With Significant Control

Change to Dr Sterghios Moschos as a person with significant control on 2023-12-13

2 Jun 2025 Officers

Termination of Huw Alun Edwards as director on 2025-06-01

1 Jun 2025 Officers

Termination of Peter Martin Hotten as director on 2025-06-01

Recent Activity

Latest Activity

Annual accounts made up to 2025-04-30

4 months ago on 27 Nov 2025

Confirmation statement made on 2025-06-12 with no updates

10 months ago on 12 Jun 2025

Change to Dr Sterghios Moschos as a person with significant control on 2023-12-13

10 months ago on 6 Jun 2025

Termination of Huw Alun Edwards as director on 2025-06-01

10 months ago on 2 Jun 2025

Termination of Peter Martin Hotten as director on 2025-06-01

10 months ago on 1 Jun 2025